We recently attended the 41st J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9th to January 12th 2023. Our overall conclusion from the conference is that the industry remains in good shape. The key themes that emerged during the week from a devices and services perspective were, the rise of value-based care and innovation & digitalisation. However, it also became clear that the macroeconomic environment is still the dominant force behind (sub) sector performance.
The investment year 2022 was not only eventful but for many also painful. While still negative, in the end,
Healthcare outperformed the market by 12.7% (MSCI World Healthcare NT vs. MSCI World NT), once again showing its resilience. To get a better understanding of 2023, healthcare executives, investors and other stakeholder groups again travelled west and made San Francisco the centre of attention of the industry, at least for a week. Pre pandemic this conference used to be extremely crowded, to the extent that sometimes it was impossible to pass through the hallways. With organisational adjustments it was slightly less full but still very well attended. The conference continues to serve as a platform for previewing full year results, meeting competitors, and occasionally announcing M&A transactions and strategy updates. Click on the link below, and find out about our key conference takeaways.